Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MannKind takes bigger 3Q loss as costs increase
Yahoo/AP
Monday, November 4, 2013 - 3:15pm
tags:
MannKind, earnings
Johnson & Johnson to pay $2.2 bln to end U.S. probes -source
Reuters
Monday, November 4, 2013 - 11:47am
tags:
kickbacks, JNJ, Natrecor, off-label, Risperdal
Will Seattle Genetics Stay Ahead of ImmunoGen and Celldex?
Motley Fool
Monday, November 4, 2013 - 10:27am
tags:
Seattle Genetics, Immunogen, Celldex
Arena Pharmaceuticals - Belviq OTC?
Seeking Alpha
Monday, November 4, 2013 - 10:10am
tags:
Belviq, OTC, Arena Pharmaceuticals, obesity, Eisai
3 Promising Biotech Stocks with Upcoming Catalysts
Wall St. Cheat Sheet
Monday, November 4, 2013 - 10:08am
tags:
Sarepta Therapeutics, eteplirsen, NeoStem, AMR-001, Celldex, CDX-110
Novartis Faces Criminal Complaint Over Diovan Research In Japan
Pharmalot
Monday, November 4, 2013 - 10:04am
tags:
Novartis, Diovan, R&D, Japan
Only Glaxo Chinese Execs May Face Charges Over Bribery Scandal
Pharmalot
Monday, November 4, 2013 - 10:03am
tags:
China, GSK, bribery
Coloplast gains on Q4, FY2013 results
Mass Device
Monday, November 4, 2013 - 10:02am
tags:
earnings, Coloplast, devices
Roche to Pay Up to $548 Million for ‘Superbug’ Antibiotic
Bloomberg
Monday, November 4, 2013 - 10:01am
tags:
Roche, antibiotics, superbugs, POL7080, Polyphor
Acorda Down on Q3 Earnings
Yahoo/Zacks
Monday, November 4, 2013 - 9:59am
tags:
earnings, Acorda Therapeutics
Can Vertex Survive Post-Incivek?
Motley Fool
Monday, November 4, 2013 - 9:59am
tags:
Vertex Pharmaceuticals, Incivek
GlaxoSmithKline says data supports Cervarix two-dose schedule for young girls
Yahoo/Fly on the Wall
Monday, November 4, 2013 - 9:58am
tags:
GSK, Cervarix, vaccines, HPV, cervical cancer
Pain drug developer Zogenix narrows 3rd quarter loss as expenses fall
Yahoo/AP
Monday, November 4, 2013 - 9:56am
tags:
earnings, Zogenix
Pfizer's Not Losing Its Kingpin Status
Yahoo/TheStreet.com
Monday, November 4, 2013 - 9:52am
tags:
Pfizer, Zoetis
Merck experimental vaccine shows promise in cancer trial
Yahoo/Reuters
Monday, November 4, 2013 - 9:52am
tags:
vaccines, Merck, V503, Gardasil, HPV
Merck: Why Oncology Smells Like Money
Seeking Alpha
Monday, November 4, 2013 - 9:49am
tags:
Merck, oncology, Roche, Bristol-Myers Squibb, MK-3475, melanoma
Bristol-Myers Vs. Abbvie In Potential Humira Rivalry
Seeking Alpha
Monday, November 4, 2013 - 9:47am
tags:
AbbVie, Humira, Bristol-Myers Squibb, clazakizumab
Vertex Failure Shows Biotech Is Not Immune To Big Pharma-Type Layoffs
Forbes
Monday, November 4, 2013 - 9:26am
tags:
Vertex Pharmaceuticals, layoffs
Achillion presents preclinical profile of HCV drug candidate
Yahoo/Fly on the Wall
Monday, November 4, 2013 - 9:19am
tags:
hepatitis C, Achillion, ACH-3422
6 Charts Explain An Ugly October for Biotech Stocks
TheStreet.com
Monday, November 4, 2013 - 9:18am
tags:
biotech, Catalyst Pharmaceutical Partners, Acadia, Celldex, Biocryst

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.